🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2017 47,80 48,80 47,00 48,65 +0,41% 3,77% 1.653.900
06/03/2017 49,95 49,95 48,40 48,45 -3,96% 3,10% 863.100
03/03/2017 49,40 50,90 48,70 50,45 +2,13% 4,45% 1.077.100
02/03/2017 48,90 53,80 48,70 49,40 -0,30% 10,43% 1.905.000
01/03/2017 56,50 58,95 47,75 49,55 +13,39% 19,82% 5.990.800
28/02/2017 45,45 45,45 43,10 43,70 -4,17% 5,17% 1.318.100
27/02/2017 43,35 45,70 43,25 45,60 +4,95% 5,65% 1.287.800
24/02/2017 44,00 44,35 42,95 43,45 -1,03% 3,18% 447.900
23/02/2017 43,15 44,60 42,75 43,90 +1,74% 4,29% 645.300
22/02/2017 44,95 44,95 42,65 43,15 -2,27% 5,12% 547.100
21/02/2017 43,75 45,10 43,50 44,15 +1,03% 3,66% 553.500
17/02/2017 43,45 44,05 42,95 43,70 +0,69% 2,53% 439.700
16/02/2017 44,15 44,43 42,80 43,40 -1,70% 3,69% 833.900
15/02/2017 42,35 44,65 42,35 44,15 +3,52% 5,43% 659.300
14/02/2017 41,40 42,78 41,15 42,65 +2,52% 3,94% 528.100
13/02/2017 42,45 42,45 41,10 41,60 -1,07% 3,18% 863.300
10/02/2017 42,40 42,80 41,30 42,05 -0,83% 3,54% 411.900
09/02/2017 42,05 43,45 42,05 42,40 +0,83% 3,33% 664.900
08/02/2017 41,50 42,40 40,85 42,05 +0,72% 3,73% 383.700
07/02/2017 42,00 42,15 41,25 41,75 -0,12% 2,14% 934.300
06/02/2017 42,45 42,95 41,50 41,80 -1,65% 3,42% 767.500
03/02/2017 42,15 42,65 41,10 42,50 +1,43% 3,68% 575.600
02/02/2017 40,15 42,30 39,85 41,90 +3,84% 6,10% 924.500
01/02/2017 38,50 41,50 38,25 40,35 +4,94% 8,44% 1.466.800
31/01/2017 36,35 38,63 35,75 38,45 +5,49% 7,92% 852.400
30/01/2017 37,20 37,20 35,90 36,45 -2,15% 3,49% 822.400
27/01/2017 37,40 38,25 36,00 37,25 -0,53% 6,02% 1.172.700
26/01/2017 38,70 39,10 37,25 37,45 -3,60% 4,78% 1.098.500
25/01/2017 41,75 41,80 38,50 38,85 -0,26% 7,90% 2.724.800
24/01/2017 39,30 39,80 38,78 38,95 -0,64% 2,60% 424.200